SAO:ONCO3

Oncoclínicas do Brasil Serviços Médicos S.A. · SAO · Healthcare · BRL · FY for 2025

Figures on this page computed 2026-11-08 13:07 UTC

Last close

n/aBRL

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
BRL
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-63.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
-5.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
4.22Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
BRL
- computed

Safety is the furthest below its sector's middle: 0.11 against 0.58 on the market's range.

Five bars, one line

lens 7 of 9

1.89x

8.50x

1.37x

1.65x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.89x
Its own average over 10 years, 3.04B.
Profit8.50x
Its own average over 10 years, -426.4M.
Free cash flow1.37x
Its own average over 10 years, -209.1M.
Debt1.65x
Its own average over 10 years, 2.30B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 8.50 times.

Sales is 1.89 times its own 10-year average; Profit is 8.50 times its own 10-year average; Free cash flow is 1.37 times its own 10-year average; Debt is 1.65 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average1.89
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
Profit against its own 10-year average8.50
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
Free cash flow against its own 10-year average1.37
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
Debt against its own 10-year average1.65
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
BRL